Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $3.9800 (-1.85%) ($3.9050 - $3.9800) on Tue. Aug. 30, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 10.69% (three month average) | RSI | 42 | Latest Price | $3.9800(-1.85%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA declines -1.2% a day on average for past five trading days. | Weekly Trend | ATRA declines -9.3% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XLC(96%) SLV(91%) IWF(88%) ARKK(87%) IBB(87%) | Factors Impacting ATRA price | ATRA will decline at least -5.345% in a week (0% probabilities). TIP(-15%) SHY(12%) TBT(23%) UUP(-38%) USO(-8%) | | | | | Relative Volatility | | | | Market Trend Strength | -5.345% (StdDev 10.69%) | Hourly BBV | -1 () | Intraday Trend | 0% | | | |
|
Resistance Level | $4.39 | 5 Day Moving Average | $4.24(-6.13%) | 10 Day Moving Average | $4.34(-8.29%) | 20 Day Moving Average | $4.39(-9.34%) | To recent high | -54.7% | To recent low | 39.4% | Market Cap | $296m | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |